Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Chapman

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 4, 2024
Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational studyKenneth R Chapman, Kathryn Cogger, Erin Arthurs, et al.
Anesthesiology|August 15, 2012
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trialJean Wong, Amir Abrishami, Yiliang Yang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 29, 2021
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD TrialRobert A Wise, Kenneth R Chapman, Benjamin M Scirica, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 16, 2011
Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPDKenneth R Chapman, Charles M Fogarty, Clare Peckitt, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 6, 2019
Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER studyAlan Kaplan, Kenneth R Chapman, Syed M Anees, et al.
Chest|September 11, 2010
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control studyLeandro G Fritscher, Theodore K Marras, Ana C Bradi, et al.
Respiratory Medicine|July 1, 2023
Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM studyKonstantinos Kostikas, Jorge F Maspero, Kenneth R Chapman, et al.
JMIR Research Protocols|November 23, 2017
Self-Management and Clinical Decision Support for Patients With Complex Chronic Conditions Through the Use of Smartphone-Based Telemonitoring: Randomized Controlled Trial ProtocolEmily Seto, Patrick Ware, Alexander G Logan, et al.
Respiratory Research|August 3, 2015
Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)Eric D Bateman, Kenneth R Chapman, Dave Singh, et al.
Respiratory Medicine|September 20, 2012
Asthma controller delay and recurrence risk after an emergency department visit or hospitalizationRichard H Stanford, Ami R Buikema, Aylin A Riedel, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 4, 2024
Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational studyKenneth R Chapman, Kathryn Cogger, Erin Arthurs, et al.
Anesthesiology|August 15, 2012
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trialJean Wong, Amir Abrishami, Yiliang Yang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 29, 2021
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD TrialRobert A Wise, Kenneth R Chapman, Benjamin M Scirica, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 16, 2011
Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPDKenneth R Chapman, Charles M Fogarty, Clare Peckitt, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 6, 2019
Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER studyAlan Kaplan, Kenneth R Chapman, Syed M Anees, et al.
Chest|September 11, 2010
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control studyLeandro G Fritscher, Theodore K Marras, Ana C Bradi, et al.
Respiratory Medicine|July 1, 2023
Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM studyKonstantinos Kostikas, Jorge F Maspero, Kenneth R Chapman, et al.
JMIR Research Protocols|November 23, 2017
Self-Management and Clinical Decision Support for Patients With Complex Chronic Conditions Through the Use of Smartphone-Based Telemonitoring: Randomized Controlled Trial ProtocolEmily Seto, Patrick Ware, Alexander G Logan, et al.
Respiratory Research|August 3, 2015
Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)Eric D Bateman, Kenneth R Chapman, Dave Singh, et al.
Respiratory Medicine|September 20, 2012
Asthma controller delay and recurrence risk after an emergency department visit or hospitalizationRichard H Stanford, Ami R Buikema, Aylin A Riedel, et al.
Pageof 18